Tipifarnib
KO-TIP-004
Phase 2 small_molecule completed
Quick answer
Tipifarnib for Leukemia, Myelomonocytic, Chronic is a Phase 2 program (small_molecule) at Kura Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Kura Oncology
- Indication
- Leukemia, Myelomonocytic, Chronic
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed